Kiran Mazumdar Shaw

Report
Kiran Mazumdar
Shaw
Life…
Born on 23rd March, 1953 in Bangalore
Schooling at Bishop Cotton Girls School & Mount Carmel College at
Bangalore
B.Sc in Zoology from Bangalore University
Qualified as a master brewer from Ballarat Universtiy, Australia
CMD, Biocon Ltd., India’s biggest Biotechnology Company
In 2004, she became India’s Richect Woman
Personal Life…
Kiran Mazumdar Shaw is married to John Shaw, a Scotsman and Indophile.
John Shaw headed a leading textiles MNC, Madura Coats from 1991 to 1998
as CMD.
Currently, John Shaw is Vice-Chairman of Biocon, Ltd.
She has huge collections of paintings and other art works.
She has also written a coffee table book named “Ale & Arty”- the story of
Beer.
Mission or Vision…??
Kiran Mazumdar Shaw personally did not believe in vision
She believed more in missions rather than vision.
Her mission was to build a biotech company that would be respected
globally.
And most importantly, she wanted to change perception that India is not
capable of a research-based business.
To her, a leader should have more missions than vision.
According to her, all leaders should be passionate about their sense of
purpose.
Quotes about Vision and
Mission..
“All leaders need not be visionaries and all visionaries need not be leaders.’’
“There can be a leader without vision but there can’t be a leader without
mission.”
“I believe that more than being a visionary, a leader must inspire people,
help them share their ideas and aspirations.”
“The vision concept is hyped and overstretched.”
Journey of Biocon…under her wings..
In 1978, she joined Biocon Biochemicals Limited, of Cork, Ireland as a
Trainee Manager.
In 1978 itself, she started Biocon in he garage in Bangalore with a capital of
Rs. 10,000.
Within a year, Biocon became the first Indian company to manufacture and
export enzymes to USA and Europe.
In 1990, she upgraded Biocon’s in-house research program, based on a
proprietary solid substrate fermentation technology.
The commercial success of this program led to a three-fold expansion by
1996 and Biocon entered the biopharmaceuticals and statins segments
In 1998, when Unilever agreed to sell its shareholding in Biocon to the
Indian promoters, Biocon became an independent entity.
In 2000, Biocon's proprietary bioreactor, christened PlafractorTM, based on
solid matrix fermentation received a U.S. patent.
By 2003 Biocon became the first company worldwide to develop human
insulin on a Pichia expression system.
In 2004, she decided to access the capital markets to develop Biocon’s
pipeline of research programs.
Biocon’s IPO was oversubscribed 32 times and its first day at the bourses
closed with a market value of $1.11 billion.
It made Biocon the 2nd only company to cross $1 billion mark on the first day
of listing.
She entered into more than 2,200 high-value R&D licensing and other deals
within the pharmaceuticals and bio-pharmaceutical space between 2005 &
2010
Biocon’s Achievement…
Med Ad News, in its 2007/08
listings has ranked Biocon 20th
amongst the leading
biotechnology companies in the
world.
Med Ad News, in its 2007/08
listings also ranked Biocon as
7th Largest Employer in the
world.
Biocon also recently received
the 2009 BioSingapore Asia
Pacific Biotechnology Award for
Best Listed Company
Personal Achievement…
1982
NATIONAL INSTITUTE OF MARKETING MANAGEMENT, INDIA
1983
ROTARY CLUB, KARNATAKA
1989
PADMASHRI, GOI
1999
INTERNATIONAL WOMENS ASSOCIATION, CHENNAI
2002
ERNST & YOUNG
2005
HIGHEST CIVILIAN HONOURS
2009
EXPRESS PHARMACEUTICAL LEADERSHIP SUMMIT AWARD
2010
FORBES LIST
THANK
YOU

similar documents